| Expression pattern: |
UP |
| Associated gene: |
ITGB1 |
| Associated microRNA: |
miR-384 |
| Biological function: |
circ-PRKCA promotes NSCLC cell malignancy; curcumin suppresses NSCLC cell viability, colony formation, migration, invasion and xenograft tumor growth by downregulating circ-PRKCA, while promoting apoptosis. |
| Molecular mechanism: |
circ-PRKCA functions as a ceRNA by sponging miR-384 to modulate ITGB1 expression in curcumin-treated NSCLC cells. |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); metastasis (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; In Vivo Animal Model; Luciferase Reporter Assay; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
- |
| Description: |
hsa_circ_0007580/circ-PRKCA is up-regulated in NSCLC tissues and cells and promotes malignant phenotypes. Curcumin suppresses NSCLC progression by downregulating circ-PRKCA, thereby relieving miR-384-mediated repression of ITGB1 and reducing viability, colony formation, migration, invasion, and xenograft tumor growth while increasing apoptosis. |
| Confidence score: |
0.742 |